Companies: 49,246 Total Market Cap: 132441797263938.02

Caregen

KOSDAQ-214370
Biological Products, Except Diagnostic Substances
Rank #8384
Market Cap 1.18 B
Volume 109,790
Price 24.21
Change (%) 4.94%
Country or region South Korea South Korea

Caregen's latest marketcap:

1.18 B

As of 05/20/2025, Caregen's market capitalization has reached $1.18 B. According to our data, Caregen is the 8384th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.18 B
Revenue (ttm) 59.40 M
Net Income (ttm) 22.23 M
Shares Out 48.87 M
EPS (ttm) 0.45
Forward PE 32.86
Ex-Dividend Date 12/27/2024
Earnings Date 05/09/2025
Market Cap Chart
Data Updated: 05/20/2025

Caregen's yearly market capitalization.

Caregen has seen its market value grow from ₩703.08 B to ₩1.66 T since 2020, representing a total increase of 136.33% and an annual compound growth rate (CAGR) of 21.65%.
Date Market Cap Change (%)
05/20/2025 ₩1.66 T 16.72%
12/30/2024 ₩1.41 T 4.43%
12/28/2023 ₩1.35 T 0.3%
12/29/2022 ₩1.35 T 106.59%
12/30/2021 ₩652.09 B -7.25%
12/30/2020 ₩703.08 B

Company Profile

About Caregen Co., Ltd.

Caregen Co., Ltd. is a biotechnology company specializing in the research, development, and commercialization of biomimetic peptides worldwide. Founded in 2001 and headquartered in Anyang-Si, South Korea, the company focuses on innovative solutions in skincare, medical treatments, and health products.

Product Portfolio

  • Filler Products: REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, CG Styler 600
  • Skincare Products: Dermaheal, PURILUX Whitening, Pim-Pim-Paul, Neovert
  • Scalp Care Products: Renokin, Pelo Baum
  • Healthy Foods: proGsterol

Research & Development

Caregen is actively developing treatments and solutions for a wide range of medical and cosmetic needs, including:

  • Medical Treatments: COVID-19, macular degeneration, diabetic retinopathy, arthritis, and more.
  • Medical Equipment: Facial beauty, scalp/hair improvement, body care.
  • Cosmetics: Wrinkle improvement, whitening, acne care, UV protection, and others.
  • Health Foods: Blood sugar control, liver function improvement, cholesterol management.

With a commitment to innovation, Caregen continues to expand its portfolio to address diverse health and beauty needs globally.

Frequently Asked Questions

As of 05/20/2025, Caregen (including the parent company, if applicable) has an estimated market capitalization of $1.18 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Caregen global market capitalization ranking is approximately 8384 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 2001
IPO Date n/a
Employees 180
CEO Yong-Ji Jeong
Sector
Industry Biological Products, Except Diagnostic Substances
Address Caregen Building
Anyang-Si, 14119
South Korea
Website https://caregen.co.kr/
People Also Watch
LON-0MTD
410.74 4.94%
ALK-Abelló A/S
227.03 4.94%
KOSDAQ-950160
26.20 4.94%
FRA-BIO
47.94 4.94%